Cita APA

Galdopórpora, J. M., Martinena, C. B., Bernabeu, E. A., Riedel, J. D., Palmas, L., Castangia, I., . . . Moretton, M. A. (2022). Inhalable Mannosylated Rifampicin–Curcumin Co-Loaded Nanomicelles with Enhanced In Vitro Antimicrobial Efficacy for an Optimized Pulmonary Tuberculosis Therapy. Web

Citación estilo Chicago

Galdopórpora, Juan Manuel, et al. Inhalable Mannosylated Rifampicin–Curcumin Co-Loaded Nanomicelles With Enhanced In Vitro Antimicrobial Efficacy for an Optimized Pulmonary Tuberculosis Therapy. 2022.

Cita MLA

Galdopórpora, Juan Manuel, et al. Inhalable Mannosylated Rifampicin–Curcumin Co-Loaded Nanomicelles With Enhanced In Vitro Antimicrobial Efficacy for an Optimized Pulmonary Tuberculosis Therapy. 2022.